冷泉港亞洲2013會(huì)議：腫瘤免疫及免疫療法
Tumor Immunology and Immunotherapy
腫瘤免疫及免疫療法
2013年10月28 – 11月1日 | 蘇州. 獨(dú)墅湖會(huì)議酒店
科學(xué)組委會(huì)成員:
Xuetao Cao, Chinese Academy of Medical Sciences, China
Xin-Yuan Fu, National University of Singapore, Singapore
Olivera Finn, University of Pittsburgh School of Medicine, USA
Cornelius Melief, Leiden University Medical Center, The Netherlands
會(huì)議主題：
1. Cancer vaccines
2. Antibody therapy
3. Adoptive T cell therapy
4. Combination of immunotherapy with other therapies
5. Cancer, inflammation and immunosuppression
6. Immune escape of cancer
7. Aging, immunity and cancer
8. Oncogenic viruses, immunity and immunotherapy
主題演講嘉賓:
David Baltimore, California Institute of Technology, USA
Engineering Immunologic Protection and Therapy
Xiaodong Wang, National Institute of Biological Sciences, China
TNFalpha and TLR3/4 induced necrosis pathway
特邀演講嘉賓:
Jean Pierre Abastado, Singapore Immunology Network, Singapore
Cancer cells hijack immune cells for dissemination and metastasis.
Jannie Borst, The Netherlands Cancer Institute, The Netherlands
Mechanistic insights in T-cell costimulation by the CD27/CD70 pathway encourage application in cancer immunotherapy
Jay Berzofsky, National Cancer Institute, USA
Cancer Vaccines: Basic strategies and clinical translation
Vincenzo Bronte, University of Verona, Italy
Molecular and metabolic control of adaptive immunity by tumor-induced myelopoiesis
Xuetao Cao, Chinese Academy of Medical Sciences, China
New cell subsets in tumor immune escape and metastasis
Yuan Chang, University of Pittsburgh Cancer Institute, USA
Merkel cell polyomavirus: a model in tumorigenesis and immunity
Lieping Chen, Yale School of Medicine, USA
Inhibiting co-inhibitors for immunotherapy of cancer
Olivera Finn, University of Pittsburgh School of Medicine, USA
Disease associated antigens as targets for cancer immunosurvellance and candidates for prophylactic cancer vaccines
Xin-Yuan Fu, National University of Singapore, Singapore
An Inducible Cancer Metastatic Niche Mediated by Endothelial STAT3
Yang-Xin Fu, The University of Chicago, USA
Changing tumor microenvironment by local ablative radiation and modified antibody for better immunotherapy
Yukai He, Georgia Regents University Cancer Center, USA
Engineering epitope-optimized AFP-based gene vaccines to prevent autochthonous hepatocellular carcinoma
Erica Jensen Jarolim, Medical University Vienna, Austria
Comparative oncology: Development of xenogenic vaccines and recombinant antibodies for dog mammary cancer patients.
Dieter Kabelitz, University of Kiel, Germany
Towards improving immunotherapeutic strategies with human gamma/delta T-cells
Yutaka Kawakami, Keio University School of Medicine, Japan
Different tumor immunoenvironments among patients and their modification by molecular targeted therapy
Binfeng Lu, University of Pittsburgh School of Medicine, USA
Danger signal IL-33 and antitumor Immunity
Ignacio Melero, University of Navarra, Spain
unfolding CD137-based cancer immunotherapy
Cornelius Melief, Leiden University Medical Center, The Netherlands
TLR-ligand peptide conjugates for superior therapeutic vaccination against immunogenic cancers
Ira Mellman, Genentech, USA
Oncology meets immunology: targeting PD-L1 in combination
Andrew Mellor, Georgia Regents University, USA
A Tale with a STING: Pivotal pathways that control immune responses to DNA
Graham Pawelec, University of Tuebingen Center for Medical Research, Germany
Immunosenescence and cancer
Zhihai Qin ,Chinese Academy of Sciences, China
S100A4(FSP-1)promotes liver fibrosis and hepatocellular carcinoma
Michel Sadelain, Memorial Sloan-Kettering Cancer Center, USA
Targeting tumors with genetically enhanced T lymphocytes
Mark Smyth, Queensland Institute of Medical Research in Brisbane, Australia
Receptor ligand interactions that regulate tumor growth and metastases
Cassian Yee, UT MD Anderson Cancer Center, USA
Adoptive T Cell Therapy of Cancer: Age of Renaissance
Hua Yu, City of Hope Duarte, USA
Pathways to Targeting STAT3: Transition into the Clinic
Rong-Fu Wang, The Methodist Hospital Research Institute Houston, USA
Innate signaling and antigen-specific cancer immunotherapy
Limin Zheng, Sun Yat-sen University, China
Macrophage Plasticity in Distinct Microenvironments of Human Tumors
Weiping Zou, University of Michigan Medical School, USA
Immune elements shape cancer stemness
|
|
聯(lián)系方式： Cold Spring Harbor Asia No.299 Qiyue Road, SIP/ Suzhou, Jiangsu Province, China Tel: +86-512-62729029 Fax: +86-512-62729028 Email: mikeji@cshl.edu Website: www.csh-asia.org |
相關(guān)鏈接： 2013年冷泉港亞洲（CSH Asia）會(huì)議搶先預(yù)覽！
- 瑞沃德將攜重磅新品亮相美國(guó)神經(jīng)科學(xué)學(xué)會(huì)年會(huì)SfN
- 東樂自然基因電生理儀器將參展CNS2024中國(guó)神經(jīng)大會(huì)
- 易科泰邀您參加中國(guó)昆蟲學(xué)會(huì)學(xué)術(shù)年會(huì)
- 預(yù)告—艾貝泰邀您參加細(xì)胞與基因治療第四屆年會(huì)
- 2025第44屆西部國(guó)際醫(yī)療器械展覽會(huì)通知
- 相約Medtec2024，睿度光電邀您共話生物芯片點(diǎn)樣技術(shù)
- 博普特成功參展2024年全國(guó)熱帶作物學(xué)術(shù)年會(huì)
- VIF World 2025第6屆疫苗創(chuàng)新國(guó)際論壇通知
- 進(jìn)科馳安邀您共聚第17屆中國(guó)神經(jīng)科學(xué)學(xué)會(huì)全國(guó)會(huì)議
- 博普特圓滿參展第二十一屆中國(guó)作物學(xué)會(huì)學(xué)術(shù)年會(huì)
- 會(huì)議：2024第23屆HUPO World Congress及PEAKS早餐會(huì)
- 南模生物邀您參加第八屆全國(guó)核酸疫苗大會(huì)
- 杭州大微受邀參加2024 IMic第十二屆工業(yè)微生物大會(huì)
- 羅輯科學(xué)精彩亮相2024年軍事病理學(xué)術(shù)會(huì)議
- IPHASE與您相約第十一次全國(guó)毒理學(xué)大會(huì)
- 賽業(yè)今晚直播：點(diǎn)突變細(xì)胞株構(gòu)建策略及其研究應(yīng)用
- 賽業(yè)講座：兩步灌流法提取原代鼠肝臟Kupffer細(xì)胞
- 賽業(yè)生物課程預(yù)告：基因編輯細(xì)胞技術(shù)及其研究應(yīng)用
- 賽業(yè)生物明日開播：CAR-T細(xì)胞的結(jié)構(gòu)設(shè)計(jì)策略
- 尚恩生物細(xì)胞特價(jià)—30株細(xì)胞系限時(shí)890元/株
- 尚恩生物——胎牛血清、原代細(xì)胞福利大放送
- 尚恩生物6月促銷：1380元超值寵粉細(xì)胞套裝限時(shí)購(gòu)
- 科德角國(guó)際正式成為ATCC菌株產(chǎn)品中國(guó)授權(quán)合作商
- 賽業(yè)生物課程預(yù)告：星形膠質(zhì)細(xì)胞培養(yǎng)和應(yīng)用
- 美森細(xì)胞與您相約2024中國(guó)衰老科學(xué)大會(huì)
- 美森細(xì)胞即將亮相BPCF第五屆北京生物藥工藝開發(fā)大會(huì)
- 美森細(xì)胞將亮相中國(guó)細(xì)胞生物學(xué)學(xué)會(huì)2024全國(guó)學(xué)術(shù)大會(huì)
- 權(quán)威專訪:中國(guó)臨床腫瘤類器官標(biāo)準(zhǔn)化建設(shè)深度解析
- 美森細(xì)胞與您相約第十一屆BioCon China Expo 2024
- 美森細(xì)胞邀您相約2024合成生物學(xué)生物醫(yī)學(xué)健康大會(huì)
Copyright(C) 1998-2024 生物器材網(wǎng) 電話：021-64166852;13621656896 E-mail：info@bio-equip.com